Teva Pharmaceutical Industries Ltd.’s women’s health unit is drawing interest from Church & Dwight Co. and Cooper Cos., people familiar with the matter said, as the troubled Israeli drugmaker sells assets to pare debt.
Teva may sell the business as a whole or split the U.S. and European operations after bidders showed interest in separate parts, the people said, asking not to be identified because the deliberations are private. Church & Dwight and Cooper are considering bids for the U.S. treatments, the people said. The deadline for final bids is as soon as this week and the entire portfolio may fetch about $2 billion, they said.
